In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions
Xconomy
MAY 31, 2017
Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the world’s most successful cancer immunotherapies, could now treat any tumor with a particular genetic fingerprint.
90 
Let's personalize your content